Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
by Mark Tullis
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
by Mark Tullis
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
by Mark Tullis
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
by Mark Tullis
Appli celebrates its first year with 10 credit union partners, $1 billion in lending calculations, and AI-powered calculators achieving 15–20% conversion rates, empowering community banks to better understand member borrowing behavior.
by Mark Tullis
Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
by Mark Tullis
Nucleus Fund invests in Provo's Terraphene, a hemp-based materials startup with a nine-figure pallet supply deal, fire- and strength-tested building materials, and a pitch to help refill the Great Salt Lake by replacing thirsty alfalfa acreage with hemp.
DHS named Fortem Technologies (Lindon, UT) the only small business among seven prime contractors on a five-year, $1B+ counter-drone IDIQ. CEO Jon Gruen discusses the win, subcontractors Lockheed Martin and Microsoft, and plans to scale Utah manufacturing.
South Jordan-based Obra emerges from stealth with two linked products, Obra Jobs and Obra Hire, betting that AI broke hiring's inbound signal and that a trust-first, outbound-focused platform can restore it.
Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
by Mark Tullis
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
by Mark Tullis
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
by Mark Tullis
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
by Mark Tullis
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
by Mark Tullis
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
by Mark Tullis
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
by Mark Tullis
Appli celebrates its first year with 10 credit union partners, $1 billion in lending calculations, and AI-powered calculators achieving 15–20% conversion rates, empowering community banks to better understand member borrowing behavior.
by Mark Tullis